Medical AI · Medical Imaging Systems
HeartFlow: Products & infrastructure
HeartFlow has 17 clinical trials on record, 6 under way. It holds 7 FDA 510(k) clearances. HeartFlow paid US doctors and teaching hospitals $2.9M in 2025, and $1.3M for research (CMS Open Payments).
Data updated Nov 22, 2026 · Back to the company report
Products
HeartFlow has 17 clinical trials on record, 6 under way. It holds 7 FDA 510(k) clearances. HeartFlow paid US doctors and teaching hospitals $2.9M in 2025, and $1.3M for research (CMS Open Payments).
17clinical trials
6trials under way
7FDA clearances
$4.2Mpaid to US doctors in 2025
Payments to US doctorsCMS Open Payments - the maker's totals, no recipient
$4.2M
$1.9M
$1.6M
Compensation For Services Other Than Consulting, Including S
a kind of payment, 2025
$1.3M
$684k
$554k
$2.9M
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 9 more records
REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Ar…
under way · 500 participants · CAD - Coronary Artery Disease
Nov 2026
REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Kno…
under way · 350 participants · CAD - Coronary Artery Disease
Oct 2026
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
under way · 5,000 participants · Coronary Artery Disease (CAD)
Mar 2026
Using CTA Measures to Define Cardiac Risk In NFL Alumni
under way · 300 participants · Coronary Artery Disease (CAD); Heart Disease; Coronary Atherosclerosis
Dec 2024
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
under way · 20,000 participants · Coronary Artery Disease
Mar 2024
The COMPLETE Study
under way · 250 participants · as a collaborator · Coronary Artery Disease
Oct 2023
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
stopped or withdrawn · 18 participants · Coronary Artery Disease
Jul 2022
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
completed · 258 participants · Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atheros…
Oct 2021
FDA 510(k) clearancesmedical devices cleared for the US market
Jul 2025
Oct 2022
Jan 2021
Aug 2019
Dec 2018
Aug 2016
Jan 2016
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
